RT Journal Article
SR Electronic
T1 The United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): Protocol for a prospective longitudinal cohort study of healthcare and ancillary workers in UK healthcare settings
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.23.21251975
DO 10.1101/2021.02.23.21251975
A1 Katherine Woolf
A1 Carl Melbourne
A1 Luke Bryant
A1 Anna L Guyatt
A1 Chris McManus
A1 Amit Gupta
A1 Robert C Free
A1 Laura Nellums
A1 Sue Carr
A1 Catherine John
A1 Christopher A Martin
A1 Louise V Wain
A1 Laura J Gray
A1 Claire Garwood
A1 Vishant Modhwadia
A1 Keith Abrams
A1 Martin D Tobin
A1 Kamlesh Khunti
A1 Manish Pareek
A1 on behalf of the UK-REACH Study Collaborative Group
A1 Manish Pareek
A1 Amani Al-Oraibi
A1 Amit Gupta
A1 Anna Guyatt
A1 Carl Melbourne
A1 Catherine John
A1 Christopher A Martin
A1 I Chris McManus
A1 Chris Orton
A1 Claire Garwood
A1 David Ford
A1 Edward Dove
A1 Fatimah Wobi
A1 Janet Hood
A1 Kamlesh Khunti
A1 Katherine Woolf
A1 Keith Abrams
A1 Laura J Gray
A1 Laura Nellums
A1 Louise V Wain
A1 Lucy Teece
A1 Luke Bryant
A1 Martin Tobin
A1 Mayuri Gogoi
A1 Osama Hassan
A1 Robert C Free
A1 Ruby Reed-Berendt
A1 Sue Carr
A1 Vishant Modhwadia
YR 2021
UL http://medrxiv.org/content/early/2021/02/25/2021.02.23.21251975.abstract
AB Introduction The COVID-19 pandemic has resulted in significant morbidity and mortality, and has devastated economies in many countries. Amongst the groups identified as being at increased risk from COVID-19 are healthcare workers (HCWs) and ethnic minority groups. Emerging evidence suggests HCWs from ethnic minority groups are at increased risk of adverse COVID-19-related physical and mental health outcomes. To date there has been no large-scale analysis of these risks in UK healthcare workers or ancillary workers in healthcare settings, stratified by ethnicity or occupation type, and adjusted for potential confounders. This paper reports the protocol for a prospective longitudinal questionnaire study of UK HCWs, as part of the UK-REACH programme (The United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers).Methods and analysis A baseline questionnaire with follow-up questionnaires at 4 and 8 months will be administered to a national cohort of UK healthcare workers and ancillary workers in healthcare settings, and those registered with UK healthcare regulators. With consent, data will be linked to health records, and participants followed up for 25 years.Univariate associations between ethnicity and primary outcome measures (clinical COVID-19 outcomes, and physical and mental health) and key confounders/explanatory variables will be tested, followed by multivariable analyses to test for associations between ethnicity and key outcomes adjusted for the confounder/explanatory variables, with interactions included as appropriate. Using follow-up data, multilevel models will be used to model changes over time by ethnic group, facilitating understanding of absolute and relative risks in different ethnic groups, and generalisability of findings.Ethics and dissemination The study is approved by Health Research Authority (reference 20/HRA/4718), and carries minimal risk to participants. We aim to manage the small risk of participant distress due to being asked questions on sensitive topics by clearly indicating on the participant information sheet that the questionnaire covers sensitive topics and that participants are under no obligation to answer these, or indeed any other, questions, and by providing links to support organisations. Results will be disseminated with reports to Government and papers uploaded to pre-print servers and submitted to peer reviewed journals.Registration details Trial ID: ISRCTN11811602STRENGTHS AND LIMITATIONS OF THIS STUDYNational, UK-wide, study, aiming to capture variety of healthcare worker job roles including ancillary workers in healthcare settings.Longitudinal study including three waves of questionnaire data collection, and linkage to administrative data over 25 years, with consent.Unique support from all major UK healthcare worker regulators, relevant healthcare worker organisations, and a Professional Expert Panel to increase participant uptake and the validity of findings.Potential for self-selection bias and low response rates, and the use of electronic invitations and online data collection makes it harder to reach ancillary workers without regular access to work email addresses.Competing Interest StatementSC is Deputy Medical Director of the General Medical Council, UK Honorary Professor, University of Leicester. KK is Director of the University of Leicester Centre for Black Minority Ethnic Health, Trustee of the South Asian Health Foundation, Chair of the Ethnicity Subgroup of SAGE and Member of Independent SAGE. LVW receives grant funding from GSK and Orion, outside of the submitted work.Clinical TrialISRCTN11811602Funding StatementUK-REACH is supported by a grant from the MRC-UK Research and Innovation (MR/V027549/1) and the Department of Health and Social Care through the National Institute for Health Research (NIHR) rapid response panel to tackle COVID-19. Core funding was also provided by NIHR Biomedical Research Centres.ALG was funded by internal fellowships at the University of Leicester from the Wellcome Trust Institutional Strategic Support Fund (204801/Z/16/Z) and the BHF Accelerator Award (AA/18/3/34220). CJ holds a Medical Research Council Clinical Research Training Fellowship (MR/P00167X/1). KK and LJG are supported by the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM). KK, MP, and RCF are supported by the NIHR Leicester Biomedical Research Centre (BRC). CAM is an NIHR Academic Clinical Fellow (ACF-2018-11-004). LBN is supported by an Academy of Medical Sciences Springboard Award (SBF005\1047). MP is supported by a NIHR Development and Skills Enhancement Award. MDT holds a Wellcome Trust Investigator Award (WT 202849/Z/16/Z) and an NIHR Senior Investigator Award. KW holds an NIHR Career Development Fellowship (CDF: CDF-2017-10-008). LVW holds a GSK/British Lung Foundation Chair in Respiratory Research (C17-1).The views expressed in the publication are those of the author(s) and not necessarily those of the National Health Service (NHS), the NIHR or the Department of Health and Social Care.This research was funded in whole, or in part, by the Wellcome Trust [WT204801/Z/16/Z and WT 202849/Z/16/Z]. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study has been approved by the Health Research Authority (Brighton and Sussex Research Ethics Committee; ethics reference: 20/HRA/4718).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesTo access data or samples produced by the UK-REACH study, the working group representative must first submit a data and material request form to the Data Access Committee (DAC) providing details for all manuscript proposals. The DAC will establish priorities for core and ancillary projects. For ancillary studies outside of the core deliverables, the Steering Committee will make final decisions once they have been approved by the Core Management Group and the DAC. Decisions on granting the access to data/materials will be made within eight weeks.Third party requests from outside the Project will require explicit approval of the Steering Committee once approved by the Core Management Group and the DAC. https://www.uk-reach.org/data-dictionary